1090-213 The sinus nodal tissue arrangement into the musculature of the terminal crest: Implications in ablation of inappropriate sinus node tachycardia?  by Angel Cabrera, José et al.
JACC March 3, 2004 ABSTRACTS - Cardiac Arrhythmias  123A
Cardiac Arrhythm
ias
POSTER SESSION
1090 
Ablation for Supraventricular Arrhythmias
Monday, March 08, 2004, Noon-2:00 p.m.
Morial Convention Center, Hall G
Presentation Hour: 1:00 p.m.-2:00 p.m.
1090-213 The Sinus Nodal Tissue Arrangement Into the 
Musculature of the Terminal Crest: Implications in 
Ablation of Inappropriate Sinus Node Tachycardia?
José Angel Cabrera, Damian Sanchez-Quintana, Siew Y. Ho, Vicente Climent, Jose M. 
Rubio, Fernando Cabestrero, Robert H. Anderson, Jeronimo Farre, Fundacion Jimenez 
Diaz, Madrid, Spain, Paediatric Cardiac Morphology; Imperial College, London, United 
Kingdom
Treatment of inappropriate sinus node tachycardia (IST) with radiofrequency (RF) cathe-
ter ablation has lower success rates than those attained in other atrial tachycardias.
Methods: In 47 normal human heart specimens (49±20 years; 31 male),we examined the
shape and dimensions of the SN by histological sections and scanning electron micro-
graphs containing the superior cavo-atrial junction.Results. Thickness of the terminal
crest ranged from 3-10 mm. The SN is generally irregular and fusiform in shape with the
uppermost portion described as the head, followed by the body and a tapering tail. In the
majority of cases the long axis of the sinus node was parallel to the terminal groove. The
nodal cells always within a matrix of connective were arranged as interlacing strands of
specialized myocytes that are smaller than working atrial myocytes. The tail of the sinus
node in 61% of specimens was separated by fibrous tissue into islands of specialised
cells. Short nodal extensions could be traced in most of the hearts passing superiorly
(0.5 to 1.5 mm in length) towards the superior vena cava (18 specimens, 38%) and inferi-
orly (0.3 to 2.3 mm in length) ending in the subepicardium (12 specimens, 25%) or
deeper into the ordinary myocardium (26 specimens, 55%).
Conclusions: The sinus nodal tissue tends to be non-uniform in shape with irregular
extensions and branching into the musculature of the terminal crest. These findings prob-
ably accounts for the difficulties during RF ablation of IST.
1090-214 Contribution of Epicardial Mapping and Ablation to 
Treatment of Patients With Previously Failed Accessory 
Pathway Ablations
Miguel Valderrabano, David A. Cesario, Sen Ji, Kevin Shannon, Isaac Wiener, Charles D. 
Swerdlow, Kalyanam Shivkumar, UCLA Medical Center, Los Angeles, CA
Background: Radiofrequency (RF) ablation has a cure rate > 90% for accessory pathway
(AP)-mediated tachycardias. Catheter instability, inadequate access to sites of interest
and epicardial APs cause ablation failures. We investigated a combined transthoracic
epicardial and endocardial approach for failed AP ablations. Methods and Results: We
reviewed 5 AP ablations obtained from 4 patients with failed ablation attempts (median 2,
range 1-4). Endocardial mapping of AP was performed using conventional techniques.
Sites with local electrograms suggestive of AP location were selected. Percutaneous
transthoracic pericardial puncture was performed via a subxiphoid approach, an 8F
sheath was inserted into the pericardium and an ablation catheter was positioned in the
epicardial aspect of the putative AP location for epicardial-endocardial electrogram com-
parison. Endocardial RF energy was applied to locations with AP potentials or the best
electrogram timing. Epicardial RF applications were performed when endocardial appli-
cations failed. Coronary arteriography was performed to assess proximity of coronary
arteries to the ablation catheter. APs were located in the right free wall (2), right poster-
oseptal (2) and midseptal (1). In 2 cases, the earliest ventricular activation during ortho-
dromic tachycardia was present in the epicardial electrogram, and AP ablation was only
successful with epicardial RF application, either alone or with simultaneous endocardial-
coronary sinus and epicardial delivery (1 case). In 2 cases, AP ablation was achieved
with endocardial RF application (optimal site location was guided by epicardial map-
ping).All APs were successfully ablated. Conclusions: A combined endocardial-epicardial
approach is useful in previously failed AP ablations. Epicardial mapping permits accurate
AP localization for both epicardial and endocardial ablation.
1090-215 Safety and Efficacy of Freezor MAX, A New 9FR, 8mm 
Tip Cryoablation Catheter for the Treatment of Atrial 
Flutter
Annibale S. Montenero, Nicola Bruno, Francesco Zumbo, Daniele Mangiameli, Andrea 
Antonelli, Stephen O'Connor, Olive Murphy, Policlinico Multimedica, Milan, Italy, 
CryoCath Technologies Inc., Montreal, Canada
Background: A new 9FR, 8mm tip, 66mm curve, quadripolar (3-5-2) cryo catheter, Free-
zor® MAX [MAX] (CryoCath, Kirkland, Canada), recently received CE Mark approval. It is
designed for use in cardiac ablation where sizeable, yet focussed lesions, are required,
such as for atrial flutter (AFl). Increased cooling to approximately –80C and better tip -
tissue contact, produce lesions 40% deeper than the 7FR 6mm tip predecessor, Free-
zor® Xtra (Xtra). Method: We investigated the safety and efficacy of MAX for the treat-
ment of AFl in 23 consecutive patients (pts), 17 (74%) male, with mean ± SD age and
arrhythmia duration of 62.7 ± 11.4 and 5.1 ± 6.2 years, respectively. 20 pts had common
AFl and 3 had uncommon AFl. EP mapping with diagnostic catheters was performed
throughout the procedure. The site for isthmus block was identified with a test freeze of
<60s, with complete block usually observed within the first 20s of the 4 minute cryo abla-
tion. Results: Acute cryo success with MAX was achieved in 22 [95.7%] of 23 pts, how-
ever, success was achieved in all 20 (100%) patients with common AFl. We compared
our MAX data with those from 98 consecutive AFl pts treated at our centre with Xtra. Sta-
tistically significantly fewer ablations (p < 0.001), 5 ± 4 vs. 17 ± 20, as well as statistically
significantly shorter (p = 0.004) fluoroscopy times, 17 ± 13 vs. 26 ± 13 mins, were
required to successfully ablate the isthmus with MAX. There were no complications in
any of the 23 pts and, of special note, no cryo energy induced AV block. All pts remained
completely discomfort free during cryo energy delivery. Conclusion: Acute success with
MAX in the 20 common AFl pts is 100%. Fluoroscopy time and the number of ablations
are statistically and clinically significantly reduced with MAX compared with Xtra. There
were no adverse events in our patient population. Our early acute experience suggests
that MAX is a safe, efficacious and improved catheter for the ablation of AFl.
1090-216 Acute Resumption of Conduction in the Cavotricuspid 
Isthmus After Catheter Ablation of Common Atrial 
Flutter: Impact of Isthmus Anatomy
Antoine Da Costa, Cécile Romeyer-Bouchard, Naïma Zarqane-Sliman, Bernard Samuel, 
Abdel Khiel, Emmanuel Faure, Karl Isaaz, University of Saint-Etienne, Saint-Etienne, 
France
Cavotricuspid isthmus conduction (CIC) is closely associated with the recurrence of atrial
flutter (AFL) and acute resumption of CIC is not unfrequent. Objectives. The aim of this
study was [1] to evaluate the prevalence of acute CIC resumption and [2] to identify its
predictors. Methods. Over 17 months, 219 pts with AFL were considered eligible; 185
pts (67±11 years; 32 females) accepted the protocol and underwent an isthmogram in
preparation for RFA (right atrium angiography). We analyzed CTI length and CTI mor-
phology was classified as straight, concave or with a pouch-like recess. RFA was per-
formed with an 8-mm-tip catheters or a cooled-tip catheter. The end-point was a bi-
directional block validated after a 30 minutes waiting period. Results: Patients character-
istics were as follows: history of AFib before ablation (86/185), structural heart disease
(77/185), LVEF (58±12%), left atrial size (43±7 mm), average CTI dimension (32±7 mm).
CTI morphology was as following: straight (n=108); concave (n=44); pouch-like recess
(n=33). Bi-directional block was obtained in 99% with a mean RF application time of
(12.8±13 min) and mean fluoroscopic time (14±13 min). During an observation of 30 min-
utes, the incidence of acute CIC restoration was 36/185 (19.5%) (mean time of 14±9
min). Among all clinical and anatomic factors tested (age, gender, structural heart dis-
ease, history of AFib, left atrial size, CTI dimension, left ventricular ejection fraction, right
atrium length, systolic pulmonary arterial pressure, significant tricuspid regurgitation,
cavo-tricuspid morphology, AFL recurrence), the only predictive factor was the presence
of an abnormal isthmus morphology [concave or pouch-like recess vs. straight aspect]:
24/77 [31%] vs. 13/108 [12%] (p=0.0025). After a mean follow-up of 9.5±5 months, AFL
recurred in 4/185 patients (2.2%), atrial fibrillation appeared in 13% (24/185) and atrial
tachycardia in one. Conclusions. The prevalence of CIC is ≈20% and the only predictive
factor of acute CIC resumption is the presence of an abnormal isthmus morphology (con-
cave aspect or pouch-like recess). Thus, a careful observation is required in this subset
immediately after AFL ablation.
1090-217 Do Single Cryothermia Applications of Less Than Five 
Minutes Produce Permanent Cavotricuspid Isthmus 
Block in Humans?
Randy Manusama, Carl Timmermans, Suzanne Philippens, Froylan Limon, Harry Crijns, 
Luz-Maria Rodriguez, Academic Hospital Maastricht, Maastricht, The Netherlands
Background: Previous animal studies showed that a cryothermia application needs to
be 5 minutes and repeated twice on the same site to create a permanent cryolesion. The
aim of this study was to compare single-3-minutes (Single-3) with double-3-minutes
(Double-3) cryothermia applications for the treatment of atrial flutter (AFL).
Methods: Forty patients (56 ± 13 years; 33 men) with common AFL were randomized to
Single-3 (n = 20) or Double-3 (n = 20) cryothermia applications at each site along the
cavotricuspid isthmus. Cryoablation was performed with the CryoCor cryoablation sys-
tem. Half of the patients had a structurally normal heart. The mean AFL cycle length was
229 ± 35 ms. A successful procedure was defined as the presence of bidirectional isth-
mus conduction block under isoproterenol infusion and non-inducibility of AFL.
Results: All but one patient (95%) of the Single-3 group and all patients (100%) of the
Double-3 group were successfully ablated. The mean temperature in the Single-3 group
was -79 ± 6°C and in the Double-3 group -80 ± 4°C (NS). The number of sites needed to
create isthmus conduction block was 9 ± 4 (Single-3) and 9 ± 2 (Double-3) (NS). Fluoros-
copy time did not differ between both groups (Single-3: 31 ± 13 and Double-3: 36 ± 17
min, NS). The procedure time of the Single-3 group was significantly shorter compared to
the procedure time of the Double-3 group (mean procedure duration 132 ± 64 versus 158
± 50 minutes, p=0.04). After a mean follow-up of 8.2 ± 4.6 months, one recurrence of
AFL occurred in the Double-3 group.
Conclusion: Single cryothermia applications of 3 minutes produce permanent cavotri-
cuspid isthmus conduction block in patients with common AFL and significantly reduce
the duration of the procedure.
Dimensions of the sinus node (mm)
Length Width Thickness
Head 2.2±1.2 (1-4) 2.4±0.7 (1-3.5) 1.2±0.3 (0.5-2.2)
Body 9.5±2.3 (6-14) 5.3±1.5 (2.2-8.3) 1.5±0.5(0.5-3.5)
Tail 1.6±0.5(1-3.5) 1.1±0.2(0.4-1.5) 0.4±0.1(0.1-0.9)
